期刊文献+

埃索美拉唑联合莫沙必利治疗胃食管反流病的临床观察 被引量:14

Clinical observation of gastroesophageal reflux disease treated by esomeprazole combined with mosapride
下载PDF
导出
摘要 目的探讨埃索美拉唑联合莫沙必利治疗胃食管反流病的效果。方法 88例胃食管反流患者随机分为治疗组48例(埃索美拉唑联合莫沙必利)及对照组40例(奥美拉唑联合莫沙必利),分别于治疗4、8周后观察患者症状缓解情况及治疗有效率。结果治疗4、8周后治疗组患者的症状缓解情况显著高于对照组(P<0.05),治疗组有效率93.7%显著高于对照组77.5%(P<0.05)。结论埃索美拉唑联合莫沙必利是治疗胃食管反流病的有效方法。 Objective To investigate the curative effect of gastroesophageal reflux disease treated by esomeprazole combined with mosapride.Methods Eighty-eight patients with GERD were randomly divided into two groups:48 patients were treated by esomeprazole combined with mosapride,40 patients were treated by omeprazole combined with mosapride.Major symptoms were evaluated four weeks and eight weeks after treatment.The cure rate was evaluated eight weeks after treatment.Results Major symptoms in the group treated by esomeprazole combined with mosapride were alleviated after treatment for four and eight weeks.The effective rate of the group treated by esomeprazole combined with mosapride(93.7%) was higher than that of the group treated by omeprazole combined with mosapride(77.5%)(P0.05).Conclusion Esomeprazole combined with mosapride is very effective in treatment of GERD.
作者 于兰 崔立红
出处 《海军总医院学报》 2010年第3期129-130,共2页 Journal of Naval General Hospital of PLA
关键词 埃索美拉唑 莫沙必利 胃食管反流病 Esomeprazole Mosapride GERD
  • 相关文献

参考文献5

二级参考文献26

  • 1Zerbib F, Bruley Des Varannes S, Scarpignato C, et al. Endogenous cholecystokinin in postprandial lower esophageal sphincter function and fundic tone in humans . Am J Physiol, 1998, 275(6 Pt 1):G1266-1273.
  • 2Hirsch DP, Mathus-Vliegen EM, Dagli U, et al . Effect of prolonged gastric distention on lower esophageal sphincter function and gastroesophageal reflux. Am J Gastroenterol,2003, 98:1696-1704.
  • 3Trudgill NJ, Riley SA. Transient low esophageal sphincter relaxations are no more frequent in patients with gastroesophageal reflux disease than in asymptomatic volunteers. Am J Gastroenterol ,2001 ,96:2569-2574.
  • 4Lehmann A, Blackshaw LA, Branden L, et al. Cannabinoid receptor agonism inhibits reansient lower esophageal sphincter relaxations and reflux in dogs. Gastroenterology ,2002, 123:1129-1134.
  • 5Kahrilas PJ, Shi G, Manka M, et al. Increased frequency of transient lower esophageal sphincter relaxation induced by gastric distention in reflux patients with hiatal hernia. Gastroenterology, 2000,118:688-695.
  • 6Hornby PJ, Abrahams TP, Partosoedarso ER. Central mechanisms of lower esophageal sphincter control. Gastroenterol Clin North Am,2002 ,31(4 Suppl):s11-20.
  • 7Grossi L, Ciccaglione AF, Travaglini N, et al. Transient lower esophageal sphincter relaxations and gastroesophageal reflux episodes in healthy subjects and GERD patients during 24 hours. Dig Dis Sci,2001,46:815-821.
  • 8Goh KL. “On-demand”therapy for gastroesophageal reflux disease: Are current proton pump inhibitors good candidates? J Gastroenterol Hepatol, 2006, 21(Suppl 5) :S115-S118.
  • 9Cheung TK, Wong BC. Proton-pump inhibitor failure/resistance: Proposed mechanisms and therapeutic algorithm. J Gastroenterol Hepatol, 2006, 21(Suppl 5):S119-S124.
  • 10Hallerback B, Unge P, Carling L, et al. Omeprazole or raniti-dine in long-term treatment of reflux esophagitis. Gastro-enterology,1994,107:1305-1311.

共引文献189

同被引文献80

引证文献14

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部